Early growth response-1 (EGR-1) –A key player in myocardial cell injury

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 12, Issue 2, 2014, Pages 66-71

  Ramadas, Nirupama ^a   Rajaraman, Barathi ^a   Kuppuswamy, Ashok A ^a   Vedantham, Srinivasan ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Atherosclerosis; EGR 1; Ischemia reperfusion injury; Myocardial cell death; Myocardial infarction; Oxidative stress; Vascular inflammation

Indexed keywords

BINDING PROTEIN; COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C3 RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 3; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PEPTIDOLEUKOTRIENE; PROTEIN BAX; PROTEIN KINASE C; PROTEIN P53; SELECTIN; SIVA 1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL DIFFERENTIATION; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HUMAN; INTIMA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULITIS; FEMALE; HEART MUSCLE ISCHEMIA; MALE; METABOLISM; PATHOPHYSIOLOGY;

EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 84924190616     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/1871525713666150123152131     Document Type: Article

References (65)

1. Blancke, F.; Claeys, M.J.; Jorens, P.; Vermeiren, G.; Bosmans, J.; Wuyts, F.L.; Vrints, C.J. Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm., 2005, 6, 385-389.
2. Yan, S.F.; Zou, Y.S.; Gao, Y.; Zhai, C.; Mackman, N. Lee, S.L.; Stern, D. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc. Natl. Acad. Sci. U.S.A., 1998, 95(14), 8298-8303.
3. Rong, Y.; Hu, F.; Huang, R.; Mackman, N.; Horowitz, J.M.; Jensen, R.L.; Brat, D.J. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res., 2006, 66(14), 7067-7074.
4. Yan, S.F.; Lu, J.; Zou, Y.S.; Soh-Won, J.; Cohen, D.M.; Buttrick, P.M.; Stern, D.M. Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem., 1999, 274(21), 15030- 15040.
5. Yan, S.F.; Lu, J.; Xu, L.; Zou, Y.S.; Tongers, J.; Kisiel, W.; Stern, D.M. Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration. J. Appl. Physiol., 2000, 88(6), 2303-2309.
6. Yan, S.F.; Fujita, T.; Lu, J.; Okada, K.; Zou, Y.S.; Mackman, N.; Stern, D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med., 2000, 6(12), 1355-1361.
7. Baron, V.; Adamson, E.D.; Calogero, A.; Ragona, G.; Mercola, D. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin. Cancer Gene Ther., 2005, 13(2), 115-124.
8. Milbrandt, J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science, 1987, 238(4828), 797-799.
9. Lau, L.F.; Nathans, D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl. Acad. Sci. U.S.A., 1987, 84(5), 1182-1186.
10. Lemaire, P.; Revelant, O.; Bravo, R.; Charnay, P. Two mouse genes encoding potential transcription factors with identical DNAbinding domains are activated by growth factors in cultured cells. Proc. Natl. Acad. Sci. U.S.A., 1988, 85(13), 4691-4695.
11. Lim, R.W.; Varnum, B.C.; Herschman, H.R. Cloning of tetradecanoyl phorbol ester-induced primary response sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. Oncogene, 1986, 1(3), 263-270.
12. Sukhatme, V.P.; Cao, X.; Chang, L.C.; Tsai-Morris, C.H.; Stamenkovich, D.; Ferreira, P.C.; Adamson, E.D. A zinc fingerencoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell, 1988, 53(1), 37-43.
13. Russo, M.W.; Sevetson, B.R.; Milbrandt, J. Identification of NAB1, a repressor of NGFI-A-and Krox20-mediated transcription. Proc. Natl. Acad. Sci. U.S.A., 1995, 92(15), 6873-6877.
14. Swirnoff, A.H.; Apel, E.D.; Svaren, J.; Sevetson, B.R.; Zimonjic, D.B.; Popescu, N.C.; Milbrandt, J.Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol. Cell Biol., 1998, 18(1), 512-524.
15. Silverman, E.S.; DU, J.; Williams, A.J.; Wadgaonkar, R.; Drazen, J.M.; Collins, T. cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). Biochem. J., 1998, 336, 183-189.
16. Yu, J.; de Belle, I.; Liang, H.; Adamson, E.D. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol. Cell., 2004, 15(1), 83-94.
17. Bae, M.H.; Jeong, C.H.; Kim, S.H.; Bae, M.K.; Jeong, J.W.; Ahn, M.Y.; Kim, K.W. Regulation of Egr-1 by association with the proteasome component C8. Biochem. Biophys. Acta., 2002, 1592(2), 163-167.
18. Yu, J.; Zhang, S.S.; Saito, K.; Williams, S.; Arimura, Y.; Ma, Y.; Mustelin, T. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO. J., 2009, 28(1), 21-33.
19. Zhang, J.; Zhang, Y.; Sun, T.; Guo, F.; Huang, S.; Chandalia, M.; Fu, M. Dietary obesity-induced Egr-1 in adipocytes facilitates energy storage via suppression of FOXC2. Sci. Rep., 2013, 3.1476.
20. Khachigian, L.M.; Lindner, V.; Williams, A.J.; Collins, T.Egr-1- induced endothelial gene expression: a common theme in vascular injury. Sci., 1996, 271(5254), 1427-1431.
21. Butcher, M.; Galkina, E.V. Old Suspect-New Evidence The Role of PKCβ in Diabetes Mellitus-Accelerated Atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2013, 33(8), 1737-1738.
22. Moens, A.L.; Claeys, M.J.; Timmermans, J.P.; Vrints, C.J. Myocardial ischemia/reperfusion-injury, A clinical view on a complex pathophysiological process. Int. J. Cardiol., 2005, 100(2), 179-190.
23. Park, J.L.; Lucchesi, B.R. Mechanisms of myocardial reperfusion injury. Ann. Thorac. Surg., 1999, 68(5), 1905-1912.
24. di Napoli, P.; Taccardi, A.A.; de Caterina, R.; Barsotti, A. Pathophysiology of ischemia-reperfusion injury: experimental data. Ital. Heart J., 2002, 3(Suppl 4), 24S-28S.
25. Lefer, A.M.; Tsao, P.S.; Lefer, D.J.; Ma, X.L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB. J., 1991, 5(7), 2029-2034.
26. Lyn, D.; Liu, X.; Bennett, N.A.; Emmett, N.L. Gene expression profile in mouse myocardium after ischemia. Physiol. Genomics, 2000, 2(3), 93-100.
27. Khachigian, L.M. Early growth response-1 in cardiovascular pathobiology. Circ. Res., 2006, 98(2), 186-191.
28. Bhindi, R.; Fahmy, R.G.; McMahon, A.C.; Khachigian, L.M.; Lowe, H.C. Intracoronary delivery of DNAzymes targeting human EGR---1 reduces infarct size following myocardial ischaemia reperfusion. J. Pathol., 2012, 227(2), 157-164.
29. Rayner, B.S.; Figtree, G.A.; Sabaretnam, T.; Shang, P.; Mazhar, J.; Weaver, J.C.; Bhindi, R. Selective Inhibition of the Master Regulator Transcription Factor Egr---1 With Catalytic Oligonucleotides Reduces Myocardial Injury and Improves Left Ventricular Systolic Function in a Preclinical Model of Myocardial Infarction. J. Am. Heart Assoc., 2013, 2(4), e000023.
30. Gill, C.; Mestril, R.; Samali, A. Losing heart: The role of apoptosis in heart disease-a novel therapeutic target? FASEB. J., 2002, 16(2), 135-146.
31. Long, X.; Boluyt, M.O.; Hipolito, M.L.; Lundberg, M.S.; Zheng, J.S.; O'Neill, L.; Crow, M.T. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest., 1997, 99(11), 2635.
32. Muthukkumar, S.; Nair, P.; Sells, S.F.; Maddiwar, N.G.; Jacob, R.J.; Rangnekar, V.M. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol. Cell. Biol., 1995, 15(11), 6262-6272.
33. Nair, P.; Muthukkumar, S.; Sells, S.F.; Han, S.S.; Sukhatme, V.P.; Rangnekar, V.M. Early growth response-1-dependent apoptosis is mediated by p53. J. Biol. Chem., 1997, 272(32), 20131-20138.
34. Vilahur, G.; Juan-Babot, O.; Peña, E.; Oñate, B.; Casaní, L.; Badimon, L. Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. J. Mol. Cell. Cardiol., 2011, 50(3), 522-533.
35. Okamura, H.; Yoshida, K.; Morimoto, H.; Haneji, T. PTEN expression elicited by EGR---1 transcription factor in calyculin A---induced apoptotic cells. J. Cell. Biochem., 2005, 94(1), 117-125.
36. Thiel, G.; Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr---1. J. Cell. Physiol., 2002, 193(3), 287-292.
37. Zins, K.; Pomyje, J.; Hofer, E.; Abraham, D.; Lucas, T.; Aharinejad, S. Egr-1 Upregulates Siva-1 Expression and Induces Cardiac Fibroblast Apoptosis. Intl. J. Mol. Sci., 2014, 15(1), 1538- 1553.
38. Cao, C.; Ren, X.; Kharbanda, S.; Koleske, A.; Prasad, K.V.S.; Kufe, D.The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J. Biol. Chem., 2001, 276(15), 11465-11468.
39. Aggeli, I.K.; Beis, I.; Gaitanaki, C. ERKs and JNKs mediate hydrogen peroxide-induced Egr-1 expression and nuclear accumulation in H9c2 cells. Physiol. Res., 2010, 59(3), 443-454.
40. Jin, N.; Hatton, N.D.; Harrington, M.A.; Xia, X.; Larsen, S.H.; Rhoades, R.A. H2O2-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells. Free Radic. Biol. Med., 2000, 29(8), 736-746.
41. Han, S.H.; Quon, M.J.; Koh, K.K. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. Curr. Opin. Lipidol., 2007, 18(1), 58-65.
42. Verma, S.; Anderson, T.J. Fundamentals of endothelial function for the clinical cardiologist. Circulation, 2002, 105(5), 546-549.
43. Moncada, S.; Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med., 1993, 329, 2002-2012.
44. Kaplanski, G.; Marin, V.; Fabrigoule, M.; Boulay, V.; Benoliel, A.M.; Bongrand, P.; Farnarier, C. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood, 1998, 92(4), 1259-1267.
45. Silverman, E.S.; Collins, T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol., 1999, 154(3), 665.
46. Manabe, I.; Shindo, T.; Nagai, R. Gene expression in fibroblasts and fibrosis involvement in cardiac hypertrophy. Circ. Res., 2002, 91(12), 1103-1113.
47. Kunjathoor, V.V.; Febbraio, M.; Podrez, E.A.; Moore, K.J.; Andersson, L.; Koehn, S.; Freeman, M.W. Scavenger receptors class AI/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem., 2002, 277(51), 49982-49988.
48. Yoshida, H.; Kondratenko, N.; Green, S.; Steinberg, D.; Quehenberger, O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J., 1998, 334, 9-13.
49. Smith, J.D.; Trogan, E.; Ginsberg, M.; Grigaux, C.; Tian, J.; Miyata, M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A., 1995, 92(18), 8264-8268.
50. Qiao, J.H.; Tripathi, J.; Mishra, N.K.; Cai, Y.; Tripathi, S.; Wang, X.P.; Rajavashisth, T.B. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol., 1997, 150(5), 1687.
51. Albrecht, C.; Preusch, M.R.; Hofmann, G.; Morris-Rosenfeld, S.; Blessing, E.; Rosenfeld, M.E.; Bea, F. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Cardiovasc. Res., 2010, 86(2), 321- 329.
52. McCaffrey, T.A.; Fu, C.; Du, B.; Eksinar, S.; Kent, K.C.; Bush, H.; Collins, T. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin. Invest., 2000, 105(5), 653-662.
53. Khachigian, L.M.; Collins, T. Early growth response factor 1: a pleiotropic mediator of inducible gene expression. J. Mol. Med., 1998, 76(9), 613-616.
54. Heo, K.S.; Kim, D.U.; Kim, L.; Nam, M.; Baek, S.T.; Park, S.K.; Hoe, K.L. Activation of PKCβ- II and PKCθ is essential for LDLinduced cell proliferation of human aortic smooth muscle cells via Gi-mediated Erk1/2 activation and Egr-1 upregulation. Biochem. Biophys. Res. Commun., 2008, 368(1), 126-131.
55. Chang, J.S.; Wendt, T.; Qu, W.; Kong, L.; Zou, Y.S.; Schmidt, A.M.; Yan, S.F. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circ. Res., 2008, 102(8), 905-913.
56. Josefsen, K.; Sùrensen, L.R.; Buschard, K.; Birkenbach, M. Glucose induces early growth response gene (Egr-1) expression in pancreatic beta cells. Diabetologia. 1999, 42, 195-203.
57. Hasan, R.N.; Phukan, S. & Harada, S. Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 988-993.
58. Gousseva, N.; Kumudhini, K.; Chesterman, C.N. & Khachigian, L.M. Early growth response factor Egr-1 mediates insulininducible vascular endothelial cell proliferation and regrowth after injury. J. Cell. Biochem., 2001, 81, 523- 534.
59. Vedantham, S.; Thiagarajan, D.; Ananthakrishnan, R.; Wang, L.; Rosario, R.; Zou, Y.S.; Goldberg, I.; Yan, S.F.; Schmidt, A.M.; Ramasamy, R. Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals. Diabetes, 2014, 63, 761- 774.
60. Hui, Y.; Funk, C.D. Cysteinyl leukotriene receptors. Biochem. Pharmacol., 2002, 64(11), 1549-1557.
61. Heise, C.E.; O'Dowd, B.F.; Figueroa, D.J.; Sawyer, N.; Nguyen, T.; Im, D.S.; Evans, J.F.Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem., 2000, 275(39), 30531-30536.
62. Takasaki, J.; Kamohara, M.; Matsumoto, M.; Saito, T.; Sugimoto, T.; Ohishi, T. & Furuichi, K. The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 Receptor. Biochem. Biophys. Res. Commun. 2000, 274(2), 316-322.
63. Lötzer, K.; Spanbroek, R.; Hildner, M.; Urbach, A.; Heller, R.; Bretschneider, E.; Habenicht, A.J. Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase-Dependent Circuits of Inflammation and Atherogenesis. Arterioscler. Thromb. Vasc. Biol., 2003, 23(8), e32-e36.
64. Jiang, W.; Hall, S.R.; Moos, M.P.; Cao, R.Y.; Ishii, S.; Ogunyankin, K.O.; Funk, C.D. Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. Am. J. Pathol., 2008, 172(3), 592-602.
65. Zhou, Y.; Zhang, Y.; Gao, F.; Guo, F.; Wang, J.; Cai, W.; Chen, Y.; Zheng, J. & Shi, G. N-n-butyl haloperidol iodide protects cardiac microvascular endothelial cells from hypoxia/ reoxygenation injury by down-regulating Egr-1 expression. Cell. Physiol. Biochem., 2010, 26 (6), 839-48.